Is it okay to treat an elderly female patient with a current urinary tract infection (UTI) and recent history of E. coli UTI treated with Macrobid (nitrofurantoin) and a respiratory infection treated with Cefdinir (cefdinir) about a month ago with Macrobid (nitrofurantoin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Yes, treating this UTI with Macrobid (nitrofurantoin) is appropriate and recommended

Nitrofurantoin remains an excellent first-line choice for this patient's symptomatic UTI, even with recent use, because resistance to nitrofurantoin is low and, importantly, decays quickly when present. 1

Why Nitrofurantoin is the Right Choice

First-Line Status Maintained

  • Nitrofurantoin is explicitly recommended as first-line therapy for acute uncomplicated cystitis in women, alongside trimethoprim-sulfamethoxazole and fosfomycin 1
  • Multiple international guidelines (AUA/CUA/SUFU 2019, EAU 2024, IDSA 2011) consistently position nitrofurantoin as a primary treatment option 1

Low Resistance Profile

  • Despite over 60 years of use, nitrofurantoin maintains excellent activity against E. coli and other common uropathogens 2, 3
  • Resistance rates remain remarkably low compared to fluoroquinolones and trimethoprim-sulfamethoxazole, which have experienced alarming increases in resistance 4, 2
  • Critically, when resistance does develop, it decays rapidly—making nitrofurantoin suitable for re-treatment 1

Prior Use is Not a Contraindication

  • The patient's previous successful treatment with Macrobid for E. coli UTI a few months ago actually supports its continued use 1
  • Guidelines specifically recommend using nitrofurantoin as a first-line agent for re-treatment 1
  • The recent cefdinir use for respiratory infection does not impact nitrofurantoin's effectiveness for UTI, as these are different drug classes targeting different sites 1

Treatment Recommendations

Dosing

  • Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days 1
  • Alternative: Nitrofurantoin macrocrystals 50-100 mg four times daily for 5 days 1
  • Treatment duration should be no longer than 7 days 1

Culture Management

  • You are correct to obtain a culture today before starting treatment—this is strongly recommended for patients with recurrent UTIs 1
  • The culture will guide therapy if symptoms don't resolve or if breakthrough occurs 1
  • Use prior culture data (the previous E. coli susceptibility) to support your empiric choice while awaiting current results 1

Important Caveats for Elderly Patients

Contraindications to Verify

  • Ensure the patient does NOT have renal impairment of any degree—nitrofurantoin is absolutely contraindicated in renal dysfunction 2, 5
  • Check creatinine clearance; avoid if CrCl <30-60 mL/min depending on guidelines 2
  • Confirm she is not in the last trimester of pregnancy (unlikely given elderly status, but verify) 1

Monitoring Considerations

  • Long-term use carries risks of pulmonary reactions and polyneuropathy, but these primarily occur with chronic prophylactic use, not short 5-day treatment courses 2, 3
  • Short-term therapy (5 days) has demonstrated good tolerability comparable to other standard regimens 2
  • The risk of serious pulmonary or hepatic adverse events is extremely low (0.001% and 0.0003% respectively) 1

Antimicrobial Stewardship Principles

Why This Choice Supports Stewardship

  • Nitrofurantoin has minimal collateral damage to normal flora compared to fluoroquinolones and broad-spectrum cephalosporins 1
  • Avoids unnecessary use of fluoroquinolones, which should be reserved for more serious infections 1
  • Using nitrofurantoin helps preserve effectiveness of broader-spectrum agents for complicated infections 1

Avoid Common Pitfalls

  • Do NOT treat if she is asymptomatic—asymptomatic bacteriuria should not be treated in elderly women with recurrent UTIs, as this fosters resistance 1
  • Do NOT classify this as "complicated UTI" unless she has structural/functional urinary tract abnormalities or immunosuppression—this leads to inappropriate broad-spectrum antibiotic use 1
  • If symptoms persist despite treatment, repeat urine culture before prescribing additional antibiotics 1

If Treatment Fails

Next Steps

  • If symptoms don't resolve by end of treatment or recur within 2 weeks, obtain repeat culture and assume resistance to nitrofurantoin 1
  • Retreat with a 7-day regimen using a different agent based on culture sensitivities 1
  • Consider second-line options: trimethoprim-sulfamethoxazole (if local resistance <20%), cephalosporins, or fosfomycin 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].

Medizinische Monatsschrift fur Pharmazeuten, 2014

Research

Drug therapy reviews: nitrofurantoin.

American journal of hospital pharmacy, 1979

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.